Record Q2 revenue grew 22% year-over-year, led by 23% MACI and 22% Burn Care growth. Net income turned positive, free cash flow surged, and full-year guidance was raised. Board authorized a $200M share repurchase program.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.